Effect of total parenteral nutrition on whole body protein kinetics in cachectic patients with benign or malignant disease. 1988

M Jeevanandam, and A Legaspi, and S F Lowry, and G D Horowitz, and M F Brennan
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.

The metabolic effects of total parenteral nutrition on malnourished cancer and noncancer patients were investigated by determining whole-body protein metabolism before and during intravenous nutritional support. The results were compared to similar studies reported in normal subjects. Primed-continuous infusion of 15N glycine was used and the isotopic enrichments in urinary urea and ammonia were measured. The end product average values were used in the calculation of whole body protein turnover. After 10 days of nutritional support in cancer and noncancer patients whole body protein breakdown decreased by 50% (p = 0.01), and 59% (p = 0.001), whereas protein synthesis decreased by 21% (p = 0.005) and 33% (p = 0.025), respectively. Protein turnover did not change in noncancer patients but increased by 15% (p = 0.005) in cancer patients. The efficiency of utilization of the endogenous supply of amino acids from the breakdown of body proteins for synthetic purposes was 77% in this group of subjects. The utilization efficiency of the intravenously infused amino acids for synthesis of body protein was 39% in cancer and noncancer patients but 51% (p less than 0.05) in normals. The data suggest that depleted patients synthesize proteins from intravenous amino acids less well than normals.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009584 Nitrogen An element with the atomic symbol N, atomic number 7, and atomic weight [14.00643; 14.00728]. Nitrogen exists as a diatomic gas and makes up about 78% of the earth's atmosphere by volume. It is a constituent of proteins and nucleic acids and found in all living cells.
D010289 Parenteral Nutrition, Total The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of TPN solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins. Hyperalimentation, Parenteral,Intravenous Hyperalimentation,Nutrition, Total Parenteral,Parenteral Hyperalimentation,Total Parenteral Nutrition,Hyperalimentation, Intravenous
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011502 Protein-Energy Malnutrition The lack of sufficient energy or protein to meet the body's metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses. Marasmus,Protein-Calorie Malnutrition,Malnutrition, Protein-Calorie,Malnutrition, Protein-Energy,Malnutritions, Protein-Energy,Protein Calorie Malnutrition,Protein Energy Malnutrition
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood

Related Publications

M Jeevanandam, and A Legaspi, and S F Lowry, and G D Horowitz, and M F Brennan
January 1996, Nutrition (Burbank, Los Angeles County, Calif.),
M Jeevanandam, and A Legaspi, and S F Lowry, and G D Horowitz, and M F Brennan
March 1987, Annals of surgery,
M Jeevanandam, and A Legaspi, and S F Lowry, and G D Horowitz, and M F Brennan
January 2000, Tumori,
M Jeevanandam, and A Legaspi, and S F Lowry, and G D Horowitz, and M F Brennan
January 1992, JPEN. Journal of parenteral and enteral nutrition,
M Jeevanandam, and A Legaspi, and S F Lowry, and G D Horowitz, and M F Brennan
January 1991, JPEN. Journal of parenteral and enteral nutrition,
M Jeevanandam, and A Legaspi, and S F Lowry, and G D Horowitz, and M F Brennan
January 2002, JPEN. Journal of parenteral and enteral nutrition,
M Jeevanandam, and A Legaspi, and S F Lowry, and G D Horowitz, and M F Brennan
January 1987, JPEN. Journal of parenteral and enteral nutrition,
M Jeevanandam, and A Legaspi, and S F Lowry, and G D Horowitz, and M F Brennan
March 1984, Cancer,
M Jeevanandam, and A Legaspi, and S F Lowry, and G D Horowitz, and M F Brennan
April 2006, The American journal of clinical nutrition,
Copied contents to your clipboard!